Treatment with the NO-synthase inhibitor, methylene blue, moderates the decrease in serum leptin concentration in streptozotocin-induced dia...

It was previously reported that serum leptin concentrations were decreased in rats with streptozotocin-induced diabetes. Also, simultaneous nitric oxide (NO)-synthase inhibitor treatment is known to partially attenuate streptozotocin-induced diabetes development. The aim of our study was to investig...

pubmed.ncbi.nlm.nih.gov